Managed a multi-million-dollar research portfolio with numerous concurrent programs, coordinating scientists, clinicians, finance, vendors, and executive leadership. Improved governance structure, reporting cadence, and stakeholder communication across the portfolio.
Served as the connective layer between scientific staff, clinical stakeholders, finance, and executive leadership on complex R&D programs, translating scientific progress into the reporting and decisions executives needed to keep programs moving.
Managed CRO and vendor relationships to keep deliverables aligned with program timelines and budget, escalating and resolving scope drift before it affected milestones.